Literature DB >> 20126851

[Gonadotrophic axis dysfunction in men with HIV-infection/aids].

Clarisse Mourão Melo Ponte1, Maria Helane Costa Gurgel, Renan Magalhães Montenegro.   

Abstract

Gonadotrophic axis dysfunction is commonly observed in HIV-infected patients. The pathogenesis is multifactorial and related to duration of HIV infection, direct cytopathic effects of viruses, use of drugs, opportunistic infections, malignancies, and malnutrition, among other factors. In men, reduced levels of testosterone is associated with loss of muscle mass and strength, decreased bone mineral density, lipodystrophy, depression, asthenia, fatigue and sexual dysfunction. In HIV-infected patients with hypogonadism, numerous studies have shown the beneficial effects of testosterone replacement on the metabolic profile and distribution of body fat, with increased body mass weight, and promote better quality of life, reduce the bone mass loss and the rates of depression. Thus, this review aimed to present a brief update of epidemiologic data, pathophysiology aspects and treatment strategies for the major abnormalities of male gonadotrophic axis associated with HIV infection and its treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20126851     DOI: 10.1590/s0004-27302009000800012

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  3 in total

1.  Effect of Different Types of Exercise in HIV + Mozambican Women Using Antiretroviral Therapy.

Authors:  Lucília Mangona; Timóteo Daca; Francisco Tchonga; Odete Bule; Nilesh Bhatt; Ilesh Jani; Albertino Damasceno; António Prista
Journal:  Open AIDS J       Date:  2015-10-20

2.  Hypogonadotropic hypogonadism in human immunodeficiency virus-infected men: uncommonly low testosterone levels.

Authors:  Ana Coelho Gomes; José Maria Aragüés; Sílvia Guerra; Joana Fernandes; Mário Rui Mascarenhas
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-09-06

3.  Iatrogenic Cushing syndrome and multifocal osteonecrosis caused by the interaction between inhaled fluticasone and ritonavir.

Authors:  Joana Figueiredo; Margarida Serrado; Nikita Khmelinskii; Sónia do Vale
Journal:  BMJ Case Rep       Date:  2020-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.